Evidence map›Paper›PMID 35022886›Full record

Trial reportSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2022

Application of interdisciplinary collaborative hospice care for terminal geriatric cancer patients: a prospective randomized controlled study.

Yong Liu, Yin Shen, Qinghua Pan, Huasheng He, Houwen Zou, Zuochao Huang, Zhiping Liu, Xiaomao Wang

Abstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. User experiences of digital health interventions among older adults with cancer: a systematic review of qualitative data.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yong LiuDepartment of Clinical Pharmacy, Ganzhou Cancer Hospital, Jiangxi, China. 871964552@qq.com.ORCID http://orcid.org/0000-0003-2088-9655
Yin ShenDepartment of Clinical Pharmacy, Ganzhou Cancer Hospital, First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi, China.
Qinghua PanDepartment of Palliative Care, Ganzhou Cancer Hospital, Ganzhou, China.
Huasheng HeDepartment of Palliative Care, Ganzhou Cancer Hospital, Ganzhou, China.
Houwen ZouScience and Education Section, Ganzhou Cancer Hospital, Ganzhou, China.
Zuochao HuangDepartment of Clinical Pharmacy, Ganzhou Cancer Hospital, Jiangxi, China.
Zhiping LiuSchool of Basic Medicine, Gannan Medical University, Ganzhou, Jiangxi, China. Zhiping.liu@gmu.edu.cn.
Xiaomao WangDepartment of Clinical Pharmacy, Ganzhou Cancer Hospital, Jiangxi, China. 2438115159@qq.com.

Funding

Ganzhou Cancer Hospital Sciences Research Scholar Program GCH-2018001
6 · The paper itself

Abstract

backgroundHospice care (HC) is specialized medical care for terminal patients who are nearing the end of life. Interdisciplinary collaborative hospice care (ICHC) is where experts from different disciplines and patients/caregivers form a treatment team to establish shared patient care goals. However, the ICHC efficacy has not been frequently studied in the terminal geriatric cancer patient (TGCP) population. This study aimed to gain insight into ICHC provided to TGCPs by an ICHC team and identify factors to ameliorate multidimensional HC.

methods166 TGCPs were randomized by a computer-generated random number table using an allocation ratio of 1:1. The patients were divided into the ICHC group and life-sustaining treatment (LST) group. The scores of these questionnaires, such as EORTC, QLQ-C30, Hamilton anxiety scale, the median survival time (MST), symptoms improvement, the median average daily cost of drugs (MADDC), the median total cost of drugs (MTDC) in the last 2 days, and medical care satisfaction were observed in both groups.

resultsAfter treatment, the improvement of emotional function and symptoms in the ICHC group were statistically higher than those in the LST group (P < 0.05). The MADDC and the MTDC in the last 2 days were statistically lower in the ICHC group than those in the LSTs group (P < 0.01). In addition, the overall satisfaction situation and the cooperation ability in the ICHC group were statistically higher than those in the LST group (P < 0.01).

conclusionThe ICHC could provide TGCPs with coordinated, comfortable, high-quality, and humanistic care.

Indexed as

Hospice CareHospicesNeoplasmsTerminal CareAgedHumansPalliative CareProspective StudiesGeriatric cancer patientsHospice careInterdisciplinary collaborative hospice careLife-sustaining treatmentsPalliative careTerminal patients

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.